{"id":"b0ee7468de69","type":"article","url":"https://hartvaat.nl/2026/02/21/erratum-sapien-3-versus-myval-bij-tavi-compare-tavi-1/","title":"Erratum: SAPIEN 3 versus Myval bij TAVI (COMPARE-TAVI 1)","title_en":"Department of Error","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":[],"journal":"The Lancet","doi":"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00315-6/fulltext","source_url":"https://doi.org/https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00315-6/fulltext","authors":[],"significance":1,"published":"2026-02-21","source_date":"2026-02-21","image":"","kennis":["https://hartvaat.nl/kennis/kleplijden/kleplijden-en-zwangerschap/"],"congress":"","summary_en":"Erratum for the COMPARE-TAVI 1 trial article by Terkelsen et al. comparing SAPIEN 3 and Myval transcatheter heart valves for TAVI.","created":"2026-07-03T10:25:18Z","updated":"2026-07-03T13:24:44Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Correctie bij het artikel van Terkelsen et al. over de gerandomiseerde vergelijking van SAPIEN 3 en Myval transkatheter hartkleppen voor TAVI in de COMPARE-TAVI 1-trial.","abstract_original":"Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the authors identified an error in the dataset that resulted in four patients being misclassified as having moderate or severe transcatheter heart valve (THV) deterioration. This misclassification does not affect the overall conclusions of the Article. Additionally, “upper CI” has been corrected to “lower CI” throughout the paper to reflect the negative risk difference."}